Mdm-2 is not induced by p53 in human keratinocytes in vivo

Journal of Cutaneous Pathology

Volumn 23, Issue 1, 1996, Pages 25-29

  Burden, A D ^a   Stables, G I ^a   Campbell, I ^a   Thomson, W ^a   MacKie, R M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN P53; THYMINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; NEGATIVE FEEDBACK; PROTEIN BINDING; SUNBURN; ULTRAVIOLET B RADIATION;

DNA DAMAGE; FEEDBACK; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SKIN; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0030060219     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb00773.x     Document Type: Article

References (25)

1. Maltzman W, Czyzyk I. UV irradiation stimulates levels of p53 cellular tumour antigen in non-transformed mouse cells. Mol Cell Biol 1984: 4: 1689.
2. Yonish-Rouach E, Resnitzky D, Lotem J et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by IL-6. Nature 1991: 352: 345.
3. Lane DP. p53, guardian of the genome. Nature 1992: 358: 15.
4. Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992: 356: 215.
5. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone and lymphoid tumours in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989: 9: 3982.
6. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990: 250: 1233.
7. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991: 351: 453.
8. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992: 69: 1237.
9. Oliner JD, Pietenpol JA, Thiagalingau S, Gyuris J, Kinzler KW, Vogelstein B. Oncoprotein mdm2 conceals the activation domain of tumour suppressor p53. Nature 1993: 362: 857.
10. Marston NJ, Crook T, Vousden KH. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild-type transformation suppressor function. Oncogene 1994: 9: 2707.
11. Fakharzadeh SS, Trusko SP, George DL. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EMBO J 1991: 10: 1565.
12. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53 - associated protein in human sarcomas. Nature 1992: 358: 80.
13. Leach FS, Tokino T, Meltzer P et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993: 53: 2231.
14. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins P. Amplification and overexpression of the mdm2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993: 53: 2736.
15. Barak Y, Juven T, Haffner R, Oren M. mdm-2 expression is induced by wild-type p53 activity. EMBOJ 1993: 12: 461.
16. Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine AJ. Identification and characterisation of multiple mdm-2 proteins and mdm-2 - p53 complexes. Oncogene 1993: 8: 2353.
17. Vojtesek B, Bártek J, Midgeley, CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992: 151: 237.
18. Roza L, Van Der Wulp KJM, MacFarlane SJ, Lohman PHM, Baan RA. Detection of cyclobutane thymine dimers in DNA of human cells with monoclonal antibodies raised against a thymine dimer-containing tetranucleotide. Photochem Photobiol 1988: 48: 627.
19. Ebert M, Yokoyama M, Kobrin MS, Friess H, Büchler MW, Korc M. Increased MDM2 expression and immunoreactivity in human pancreatic ductal adenocarcinoma. Int J Oncol 1994: 5: 1279.
20. Roza L, Vermeulen W, Henegouwen B et al. Effects of photoreactivating enzyme on thymine dimer removal and DNA repair synthesis in normal human and xeroderma pigmentosum fibroblasts. Cancer Res 1990: 50: 1905.
21. Roza L, De Gruijl, Henegouwen J et al. Detection of photorepair of UV - induced thymine dimers in human epidermis by immunofluorescence microscopy. J Invest Dermatol 1991: 96: 903.
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991: 51: 6304.
23. Hall PA, McKee PH, Menage H, Dover R, Lane DP. High levels of p53 protein in UV - irradiated normal human skin. Oncogene 1993: 8: 203.
24. Campbell C, Quinn AG, Angus B, Farr PM, ReesJ L. Wave-length specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 1993: 53: 2697.
25. Otto A, Deppert W. Upregulation of mdm2 expression in MethA tumor cells tolerating wild-type p53. Oncogene 1993: 8: 2591.